Følg
Mikael Skurnik
Mikael Skurnik
University of Helsinki
Verifisert e-postadresse på helsinki.fi - Startside
Tittel
Sitert av
Sitert av
År
Bacterial polysaccharide synthesis and gene nomenclature
PR Reeves, M Hobbs, MA Valvano, M Skurnik, C Whitfield, D Coplin, ...
Trends in microbiology 4 (12), 495-503, 1996
6501996
Phage therapy: facts and fiction
M Skurnik, E Strauch
International Journal of Medical Microbiology 296 (1), 5-14, 2006
4692006
Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function
N Ottman, J Reunanen, M Meijerink, TE Pietilä, V Kainulainen, J Klievink, ...
PloS one 12 (3), e0173004, 2017
4432017
A Novel Erythromycin Resistance Methylase Gene (ermTR) in Streptococcus pyogenes
H Seppälä, M Skurnik, H Soini, MC Roberts, P Huovinen
Antimicrobial agents and chemotherapy 42 (2), 257-262, 1998
3781998
YadA, the multifaceted Yersinia adhesin
Y El Tahir, M Skurnik
International Journal of Medical Microbiology 291 (3), 209-218, 2001
3662001
Characterization of the O‐antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O‐antigen gene cluster of Yersinia pestis shows that the plague bacillus is …
M Skurnik, A Peippo, E Ervelä
Molecular microbiology 37 (2), 316-330, 2000
3452000
The surface‐located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis
Å Forsberg, AM Viitanen, M Skurnik, H Wolf‐Watz
Molecular microbiology 5 (4), 977-986, 1991
3371991
Increased virulence of Yersinia pseudotuberculosis by two independent mutations
R Rosqvist, M Skurnik, H Wolf-Watz
Nature 334 (6182), 522-525, 1988
3361988
Biotechnological challenges of phage therapy
M Skurnik, M Pajunen, S Kiljunen
Biotechnology letters 29, 995-1003, 2007
2822007
Direct amplification of rRNA genes in diagnosis of bacterial infections
K Rantakokko-Jalava, S Nikkari, J Jalava, E Eerola, M Skurnik, ...
Journal of Clinical Microbiology 38 (1), 32-39, 2000
2802000
Bacteriophage φYeO3-12, Specific forYersinia enterocolitica Serotype O:3, Is Related to Coliphages T3 and T7
M Pajunen, S Kiljunen, M Skurnik
Journal of bacteriology 182 (18), 5114-5120, 2000
2662000
Quality and safety requirements for sustainable phage therapy products
JP Pirnay, BG Blasdel, L Bretaudeau, A Buckling, N Chanishvili, JR Clark, ...
Pharmaceutical research 32, 2173-2179, 2015
2592015
Analysis of the yopA gene encoding the Yop1 virulence determinants of Yersinia spp.
M Skurnik, H Wolf‐Watz
Molecular microbiology 3 (4), 517-529, 1989
2591989
The Yersinia adhesin YadA collagen‐binding domain structure is a novel left‐handed parallel β‐roll
H Nummelin, MC Merckel, JC Leo, H Lankinen, M Skurnik, A Goldman
The EMBO journal 23 (4), 701-711, 2004
2422004
Temperature‐regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia
JA Bengoechea, M Skurnik
Molecular microbiology 37 (1), 67-80, 2000
2212000
Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
RM Dedrick, BE Smith, M Cristinziano, KG Freeman, D Jacobs-Sera, ...
Clinical infectious diseases 76 (1), 103-112, 2023
2202023
Erythromycin resistance genes in group A streptococci in Finland
J Kataja, P Huovinen, M Skurnik, ...
Antimicrobial Agents and Chemotherapy 43 (1), 48-52, 1999
2091999
Parallel independent evolution of pathogenicity within the genus Yersinia
S Reuter, TR Connor, L Barquist, D Walker, T Feltwell, SR Harris, ...
Proceedings of the National Academy of Sciences 111 (18), 6768-6773, 2014
2062014
Virulence plasmid-associated autoagglutination in Yersinia spp
M Skurnik, I Bölin, H Heikkinen, S Piha, H Wolf-Watz
Journal of bacteriology 158 (3), 1033-1036, 1984
1951984
Molecular and chemical characterization of the lipopolysaccharide O‐antigen and its role in the virulence of Yersinia enterocolitica serotype O:8
L Zhang, J Radziejewska‐Lebrecht, D Krajewska‐Pietrasik, P Toivanen, ...
Molecular microbiology 23 (1), 63-76, 1997
1921997
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20